Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Partial myeloid inhibition of key glycolytic enzyme PFKFB3 increases hepatic steatosis and inflammation, but does not affect atherosclerosis
R. Tillie, Joost D. de Bruijn, Ross Dobie, Javier Perales-Patón, Kim van Kuijk, Marion J. Gijbels, Lieve Temmerman, Yanal Ghosheh, Gijs H. Goossens, Peter Carmeliet, Klaus Ley, Neil C. Henderson, Julio Sáez-Rodríguez, Kristiaan Wouters, Judith C. Sluimer (2023). Partial myeloid inhibition of key glycolytic enzyme PFKFB3 increases hepatic steatosis and inflammation, but does not affect atherosclerosis. , 379, DOI: https://doi.org/10.1016/j.atherosclerosis.2023.06.961.
Article64 days agoPartial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis
R. Tillie, Jenny de Bruijn, Javier Perales-Patón, Lieve Temmerman, Yanal Ghosheh, Kim van Kuijk, Marion J. Gijbels, Peter Carmeliet, Klaus Ley, Julio Sáez-Rodríguez, Judith C. Sluimer (2021). Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis. , 9, DOI: https://doi.org/10.3389/fcell.2021.695684.
Article64 days ago